Department of Health Sciences, University of York, York, UK.
Research Department of Primary Care and Population Health, UCL, London, UK.
Addiction. 2018 Apr;113(4):708-718. doi: 10.1111/add.14086. Epub 2017 Dec 11.
To assess the cost-effectiveness of a two-component intervention designed to increase attendance at the NHS Stop Smoking Services (SSSs) in England.
Cost-effectiveness analysis alongside a randomized controlled trial (Start2quit).
NHS SSS and general practices in England.
The study comprised 4384 smokers aged 16 years or more identified from medical records in 99 participating practices, who were motivated to quit and had not attended the SSS in the previous 12 months.
Intervention was a personalized and tailored letter sent from the general practitioner (GP) and a personal invitation and appointment to attend a taster session providing information about SSS. Control was a standard generic letter from the GP advertising SSS and asking smokers to contact the service to make an appointment.
Costs measured from an NHS/personal social services perspective, estimated health gains in quality-adjusted life-years (QALYs) measured with EQ-5D and incremental cost per QALY gained during both 6 months and a life-time horizon.
During the trial period, the adjusted mean difference in costs was £92 [95% confidence interval (CI) = -£32 to -£216) and the adjusted mean difference in QALY gains was 0.002 (95% CI = -0.001 to 0.004). This generates an incremental cost per QALY gained of £59 401. The probability that the tailored letter and taster session is more cost-effective than the generic letter at 6 months is never above 50%. In contrast, the discounted life-time health-care cost was lower in the intervention group, while the life-time QALY gains were significantly higher. The probability that the intervention is more cost-effective is more than 83% using a £20 000-30 000 per QALY-gained decision-making threshold.
An intervention designed to increase attendance at the NHS Stop Smoking Services (tailored letter and taster session in the services) appears less likely to be cost-effective than a generic letter in the short term, but is likely to become more cost-effective than the generic letter during the long term.
评估旨在提高英格兰国民保健服务(NHS)戒烟服务(SSS)就诊率的两部分干预措施的成本效益。
随机对照试验(Start2quit)的成本效益分析。
英格兰 NHS SSS 和一般实践。
该研究包括从 99 家参与实践的医疗记录中确定的 4384 名年龄在 16 岁或以上的吸烟者,他们有戒烟的动机,并且在过去 12 个月内没有参加 SSS。
干预措施是由全科医生(GP)发出的个性化和定制的信件,以及个人邀请和预约参加提供有关 SSS 信息的品尝课程。对照组是由全科医生发出的标准通用信件,宣传 SSS 并要求吸烟者联系服务以预约。
从 NHS/个人社会服务角度测量成本,使用 EQ-5D 衡量健康收益的质量调整生命年(QALY),并在 6 个月和终身期间内计算每获得一个 QALY 的增量成本。
在试验期间,调整后的成本平均差异为 £92 [95%置信区间(CI)= -£32 至 -£216],调整后的 QALY 收益平均差异为 0.002(95%CI = -0.001 至 0.004)。这产生了每获得一个 QALY 的增量成本为 £59401。在 6 个月时,定制信件和品尝课程比通用信件更具成本效益的概率从未超过 50%。相比之下,干预组的终身健康保健成本较低,而终身 QALY 收益显著更高。在使用 £20000-30000 每 QALY 收益的决策阈值时,干预措施更具成本效益的概率超过 83%。
旨在提高 NHS 戒烟服务就诊率的干预措施(服务中的定制信件和品尝课程)在短期内可能不如通用信件具有成本效益,但从长期来看,它可能比通用信件更具成本效益。